Search
Publications 2017

1 Predictors of eGFR Progression, Stabilisation or Improvement After Chronic Renal Impairment in HIV-positive individuals. L Ryom, A MOcroft, O Kirk, M Ross, C Smith, O Moranne, P Morlat, CA FUX; C Sabin, A Phillips, M Law, JD Lundgren. On behalf of the D:A:D Study group.
AIDS. 2017 Mar 28.  [Epub ahead of print]. abstract


2 Are we successfully managing cardiovascular disease in people living with HIV? CI Hatleberg, JD Lundgren, L Ryom.
Curr Opin HIV AIDS. 2017;12(6):594-603. Abstract 

3 Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study. MA Boyd, A Mocroft, L Ryom, AD Monforte, C Sabin , WM El-Sadr,  CIHatleberg, S De Wit, R Weber, E Fontas, A Phillips, F Bonnet, P Reiss, J Lundgren, M Law.
PLoS Med. 2017 ;14(11):. eCollection 2017 Nov. Abstract

IN PRESS: 

1 Differences in virological and immunological risk factors for non-Hodgkin and Hodgkin lymphoma: The D:A:D Study"

L Shepherd, L Ryom, M Law, C Ingrid Hatleberg, S de Wit, A d'Arminio Monforte, M Battegay, A Phillips, F Bonnet, P Reiss, C Pradier, A Grulich, C Sabin, J Lundgren, A Mocroft,
Journal of the National Cancer Institute